2017•Faculty Opinions – Post-Publication Peer Review of the Biomedical LiteratureOpen access

Faculty Opinions recommendation of Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.

Varsha Gandhi, Prithviraj Bose

Abstract

Read the full review for this Faculty Opinions recommended article: Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Bendamustine, Medicine, Chronic lymphocytic leukemia, Internal medicine, Oncology, Leukemia